US 9409994
High-affinity monoclonal antibodies to glypican-3 and use thereof
granted A61KA61K2039/505A61K38/45
Quick answer
US patent 9409994 (High-affinity monoclonal antibodies to glypican-3 and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 33
- CPC classes
- A61K, A61K2039/505, A61K38/45, A61K47/6851, A61K47/6869